================================================================================

                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549
                                ________________

                                   SCHEDULE TO
                             TENDER OFFER STATEMENT
                                      UNDER
                       SECTION 14(D)(1) OR 13(E)(1) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

                                ________________

                              EVOLVE SOFTWARE, INC.
         (NAME OF SUBJECT COMPANY (ISSUER) AND FILING PERSON (OFFEROR))

          OPTIONS TO PURCHASE COMMON STOCK, PAR VALUE $0.001 PER SHARE
                         (TITLE OF CLASS OF SECURITIES)
                                      N/A*
                      (CUSIP NUMBER OF CLASS OF SECURITIES)

                               KENNETH J. BOZZINI
                             CHIEF FINANCIAL OFFICER
                              EVOLVE SOFTWARE, INC.
                           1400 65TH STREET, SUITE 100
                              EMERYVILLE, CA 94608
                                 (510) 428-6000
 (NAME, ADDRESS AND TELEPHONE NUMBER OF PERSON AUTHORIZED TO RECEIVE NOTICES AND
                   COMMUNICATIONS ON BEHALF OF FILING PERSON)

                                   COPIES TO:

                             LARRY W. SONSINI, ESQ.
                               RAMSEY HANNA, ESQ.
                        WILSON SONSINI GOODRICH & ROSATI,
                            PROFESSIONAL CORPORATION
                               650 PAGE MILL ROAD
                        PALO ALTO, CALIFORNIA 94304-1050
                                 (650) 493-9300

                            CALCULATION OF FILING FEE
================================================================================
              TRANSACTION VALUATION+                        AMOUNT OF FILING FEE
--------------------------------------------------------------------------------
$     333,304 . . . . . . . . . . . . . . . . . . . . . .   $              66.66
================================================================================

+    Calculated  solely  for purposes of determining the filing fee. This amount
     assumes that options to purchase 1,822,690 shares of common stock of Evolve
     Software, Inc. having an aggregate value of $333,304 as of December 4, 2001
     will  be  exchanged  and/or cancelled pursuant to this offer. The aggregate
     value  of  such  options  was  calculated based on the Black-Scholes option
     pricing  model. The amount of the filing fee, calculated in accordance with
     Rule  0-11(b)  of  the  Securities Exchange Act of 1934, as amended, equals
     1/50th  of  one  percent  of  the  value  of  the  transaction.

[ ]  Check  the  box  if  any  part  of the fee  is  offset as  provided by Rule
     0-11(a)(2)  and  identify  the  filing  with  which  the offsetting fee was
     previously  paid.  Identify  the  previous filing by registration statement
     number,  or  the  Form  or  Schedule  and  the  date  of  its  filing.
                    AMOUNT PREVIOUSLY PAID: NOT APPLICABLE.
                   FORM OR REGISTRATION NO.: NOT APPLICABLE.
                         FILING PARTY: NOT APPLICABLE.
                          DATE FILED: NOT APPLICABLE.
[ ]  Check  the  box if the filing relates solely to preliminary  communications
     made  before  the  commencement  of  a  tender  offer.

Check  the  appropriate  boxes  below to designate any transactions to which the
statement  relates:

[ ]  third  party  tender  offer  subject  to  Rule  14d-1.
[X]  issuer  tender  offer  subject  to  Rule  13e-4.
[ ]  going-private  transaction  subject  to  Rule  13e-3.
[ ]  amendment  to  Schedule  13D  under  Rule  13d-2.

Check the following box if the filing is a final amendment reporting the results
of  the  tender  offer:  [ ]

  *     There  is  no trading market or CUSIP Number for the options. The CUSIP
Number  for  the  underlying  common  stock  is  30049P104.
================================================================================



ITEM  1.  SUMMARY  TERM  SHEET.

     The  information  set  forth under "Offer Summary" in the Offer to Exchange
all  Outstanding  Options  for  New  Options  dated  December 5, 2001 ("Offer to
Exchange"),  a  copy  of  which  is  attached  hereto  as  Exhibit  (a)(1),  is
incorporated  herein  by  reference.

ITEM  2.  SUBJECT  COMPANY  INFORMATION.

     (a)     The  name  of  the  issuer  is  Evolve  Software  Inc.,  a Delaware
corporation  ("Evolve" or the "Company"). The address of its principal executive
offices  is  1400  65th  Street,  Suite  100,  Emeryville, California 94608. The
telephone  number  at  that  address  is  (510)  428-6000.

     (b)     This  Tender  Offer Statement on Schedule TO relates to an offer by
the  Company  to  exchange  options  outstanding  under the Company's 1995 Stock
Option  Plan  and  the  Company's 2000 Stock Plan (collectively, the "Plans") to
purchase approximately 1,822,690 shares of the Company's Common Stock, par value
$0.001  per  share ("Option Shares"), for new options that will be granted under
the  Evolve  Software,  Inc. 2000 Stock Plan (the "New Options"), upon the terms
and  subject  to  the  conditions  set  forth  under "The Offer" in the Offer to
Exchange.  Persons who are not employees of Evolve or one of its subsidiaries or
who  do  not  live  and work in the United States are not eligible to accept the
Offer. Persons who are Section 16 officers of Evolve are also not be eligible to
accept  the  Offer.  The information set forth under "The Offer" in the Offer to
Exchange  is  incorporated  herein  by  reference.


     (c)     The  information set forth in the Offer to Exchange under Section 8
("Price  range  of  shares  underlying  the  options") is incorporated herein by
reference.

ITEM  3.  IDENTITY  AND  BACKGROUND  OF  FILING  PERSON.

     (a)     The  filing  person  is the issuer. The information set forth under
Item  2(a)  above  is  incorporated  herein  by  reference.

ITEM  4.  TERMS  OF  THE  TRANSACTION.

     (a)     The  information  set  forth  in the Offer to Exchange under "Offer
Summary,"  Section  2  ("Number  of  options;  expiration  date"),  Section  4
("Procedures  for  tendering options"), Section 5 ("Withdrawal rights and change
of  election"),  Section  6 ("Acceptance of options for exchange and issuance of
new  options"),  Section  7  ("Conditions of the offer"), Section 9 ("Source and
amount  of consideration; terms of new options"), Section 12 ("Status of options
acquired  by us in the offer; accounting consequences of the offer"), Section 13
("Legal  matters;  regulatory  approvals"),  Section  14 ("Material U.S. federal
income  tax  consequences"),  and  Section 15 ("Extension of offer; termination;
amendment")  are  incorporated  herein  by  reference.

     (b)     The information set forth in the Offer to Exchange under Section 11
("Interests  of directors and officers; transactions and arrangements concerning
the  options")  is  incorporated  herein  by  reference.

ITEM  5.  PAST  CONTACTS,  TRANSACTIONS,  NEGOTIATIONS  AND  ARRANGEMENTS.

     (e)  (i)     Evolve  currently  has  reserved  4,117,971  shares subject to
options granted  pursuant to the Company's 2000 Stock Plan and 1995 Stock Option
Plan, in  the  aggregate.



          (ii)    Evolve  completed  a  sale  of  Series A  Preferred Stock (the
"Series  A Preferred Financing") on October 9, 2001. As a result of the Series A
Preferred  Financing  the  Company  currently  has  outstanding  the  following
securities  and  rights  held  by  the  investors  participating  therein:

-    an  aggregate  of  1.3  million  shares of the Company's Series A Preferred
     Stock  at  a  price  of  $10  per  share

-    warrants to purchase up to an aggregate of 1.3 million additional shares of
     Series  A Preferred Stock at a price of $10 per share (the "Preferred Stock
     Warrants")

-    warrants to purchase up to 6.5 million shares of Common Stock at a price of
     $1.00  per  share  (the  "Common  Stock  Warrants")

-    the  right to receive additional Common Stock Warrants to purchase a number
     of  shares  of  Common Stock equal to 25% of the number of shares of Common
     Stock  into  which  the  shares  of  Series  A  Preferred Stock issued upon
     exercise  of the Preferred Stock Warrants are convertible, at the time such
     Preferred  Stock  Warrants  are  exercised.

     Conversion  Rights  /  Anti-Dilution  Adjustment.  Each  share  of Series A
Preferred  Stock is convertible into Common Stock at an initial conversion price
of $0.50, or at an initial conversion rate of 20 shares of Common Stock for each
share  of  Series  A Preferred Stock.  The conversion rate accretes at a rate of
8.00%  per annum.  The conversion rate is also subject to certain adjustments as
set  forth  in the Certificate of Designation of Series A Preferred Stock of the
Company  (attached  hereto  as  Exhibit  (d)(1)), in the event of dilutive stock
issuances  by  the  Company  and  in  the event the Company incurs litigation or
tax-related  expenses  in  excess of certain limitations. The Series A Preferred
Stock  may be converted at any time at the election of each holder.  The Company
may  cause  all  of  the  shares of Series A Preferred Stock to be automatically
converted  into Common Stock at any time after the fifth anniversary of the date
of  initial  issuance  of  these shares, provided that the Common Stock has been
trading  at  a  value  of  at  least  $5.00  for  a  specified  period.

     Liquidation  Preference.  In  the  event  of  a  transaction  involving  a
dissolution  of  the  Company,  the  holders of Series A Preferred Stock will be
entitled  to  payment  of a liquidation preference equal to the initial purchase
price  of their shares of Series A Preferred Stock, plus an 8.00% annual rate of
return,  prior  to  any  payment  to  holders  of  Common Stock and other junior
securities.  In  the event of certain transactions involving a change of control
of  the Company, a liquidation preference equal to the initial purchase price of
the  Series A Preferred shares held plus an 8.00% rate of return computed over a
five-year  period  is  payable  to  the  holders  of  Series  A Preferred Stock,
irrespective  of  when  such  a  transaction  occurs.

     Voting  Rights.  Holders of Series A Preferred Stock are generally entitled
to  one  vote for each share of Common Stock into which their Series A Preferred
Stock  is  convertible,  subject  to  certain  protective  provisions.

     Board  Representation.  The holders of the Series A Preferred Stock, voting
as  a separate class, are entitled to elect three members to the Company's Board
of  Directors,  subject  to  reduction  upon  certain  events.

     Preferred  Stock  Warrants. The Preferred Stock Warrants are exercisable to
purchase up to an aggregate of 1.3 million shares of Series A Preferred stock at
a  Common  Stock-equivalent  price  of  $.50  per  share, payable in cash. Fifty
percent  of  the Preferred Stock Warrants expire if not exercised within 30 days
after  the  Company's appointment of a new permanent Chief Executive Officer. If
these  first  warrants  are exercised in full, then the balance of the Preferred
Stock Warrants may be exercised for up to one year after issuance. Forms of such
warrants  are  attached  hereto  as  Exhibit  (d)(2).


                                                                             -2-

     Common  Stock  Warrants.  The Common Stock Warrants issued to the investors
are  exercisable  for  up to 6.5 million shares of Common Stock, and the Company
will issue warrants to purchase up to an additional 6.5 million shares of Common
Stock  if  the  Preferred Stock Warrants are exercised in full. The Common Stock
Warrants  have  an  exercise  price  of  $1.00  per  share,  which is subject to
adjustment  if  the Company issues securities at less than fair market value and
under  certain  other  circumstances. The Common Stock Warrants may be exercised
for  cash, or on a cashless basis by converting the Common Stock Warrants into a
number  of  shares  with a value equal to the spread between the market value of
the  shares  subject  to  the  Common  Stock Warrants and the exercise price. In
addition,  in the event of certain transactions involving a change of control of
the  Company,  holders  of  Common Stock Warrants will have the right to deliver
these Warrants to the Company in exchange for payments equal to the market value
of  such  warrants  at the time of the change of control transaction, payable in
cash  or,  subject to certain conditions, shares of Common Stock of the Company.
The Common Stock Warrants have a term of seven years. A form of such warrants is
attached  hereto  as  Exhibit  (d)(3).

     Preemptive  Rights.  The Company has granted to the holders of the Series A
Preferred  Stock rights to maintain their percentage ownership in the Company by
purchasing  additional  shares in connection with future equity issuances by the
Company.

     Registration  Rights.  The  Company has agreed to prepare and file with the
Securities  and  Exchange  Commission,  upon  request of the holders of Series A
Preferred Stock after June 1, 2002, registration statements to enable the resale
of the shares of Common Stock issued or issuable upon conversion of the Series A
Preferred  Stock  and  the  Warrants.

ITEM  6.  PURPOSES  OF  THE  TRANSACTION  AND  PLANS  OR  PROPOSALS.

     (a)     The  information set forth in the Offer to Exchange under Section 3
("Purpose  of  the  offer")  is  incorporated  herein  by  reference.

     (b)     The information set forth in the Offer to Exchange under Section 12
("Status  of options acquired by us in the offer; accounting consequences of the
offer")  is  incorporated  herein  by  reference.

     (c)     The  information set forth in the Offer to Exchange under Section 3
("Purpose  of  the  offer")  is  incorporated  herein  by  reference.

ITEM  7.  SOURCE  AND  AMOUNT  OF  FUNDS  OR  OTHER  CONSIDERATION.

     (a)     The  information set forth in the Offer to Exchange under Section 9
("Source  and  amount  of  consideration;  terms of new options") and Section 16
("Fees  and  expenses")  is  incorporated  herein  by  reference.

     (b)     Not  applicable.

     (d)     Not  applicable.

ITEM  8.  INTEREST  IN  SECURITIES  OF  THE  SUBJECT  COMPANY.

     (a)     Not  applicable.

     (b)     The information set forth in the Offer to Exchange under Section 11
("Interests  of directors and officers; transactions and arrangements concerning
the  options")  is  incorporated  herein  by  reference.


                                                                             -3-

ITEM  9.  PERSON/ASSETS,  RETAINED,  EMPLOYED,  COMPENSATED  OR  USED.

     (a)     Not  applicable.

ITEM  10.  FINANCIAL  STATEMENTS.

     (a)     The  information  set  forth  on pages F-1 through F-26 of Evolve's
Annual  Report  on  Form  10-K  for  its  fiscal year ended June 30, 2001, which
contains  Evolve's  financial  statements  for such fiscal year, is incorporated
herein  by  reference.  The  information  set  forth  on  pages  2 through 11 of
Evolve's  Quarterly  Report  on  Form  10-Q  for  its first fiscal quarter ended
September 30, 2001, which contains Evolve's financial statements for such fiscal
quarter,  is  incorporated  herein  by  reference.

     (b)     Not  applicable.

ITEM  11.  ADDITIONAL  INFORMATION.

     (a)     The information set forth in the Offer to Exchange under Section 13
("Legal  matters;  regulatory  approvals")  is incorporated herein by reference.

     (b)     Not  applicable.

ITEM  12.  EXHIBITS.

     (a)    (1)    (i)    Offer  to Exchange Certain Outstanding Options for New
                   Options,  dated  December  5,  2001.

                   (ii)   Election  Form.

                   (iii)  Letter from Chairman to Employees, dated December 5,
                   2001.

                   (iv)   Form  of  Notice  to  Withdraw  from  the  Offer.

                   (v)    Form  of  Promise  to  Grant  Stock  Option(s).

            (5)    (i)    Evolve  Software, Inc. Amended and Restated 2000 Stock
                   Plan.

                   (ii)   Form of agreement under Evolve Software, Inc. Amended
                   and Restated 2000 Stock Plan.

                   (iii)  Evolve Software, Inc. 2000 Stock Plan Prospectus.

     (b)    Not  applicable.

     (d)    (1)    Certificate of Designation of  Evolve Software, Inc. Series A
            Preferred  Stock,  filed  as  Exhibit 10.4 to the Company's  Current
            Report  on  Form  8-K/A  filed  on October 3, 2001, and incorporated
            herein by reference.

            (2)    Form  of  Form  A  Subscription  Warrant  and  Form of Form B
            Subscription Warrant, filed as Exhibit 10.2 to the Company's Current
            Report  on  Form 8-K/A  filed  on October 3, 2001,  and incorporated
            herein by reference.


                                                                             -4-

            (3)    Form  of Warrant to Purchase Shares of Common Stock, filed as
            Exhibit  10.3 to the Company's Current Report on Form 8-K/A filed on
            October 3, 2001,  and  incorporated  herein  by  reference.

     (g)    Not  applicable.

     (h)    Not  applicable.

ITEM  13.  INFORMATION  REQUIRED  BY  SCHEDULE  13E-3.

     (a)    Not  applicable.


                                                                             -5-

                                    SIGNATURE

     After  due  inquiry  and  to the best of my knowledge and belief, I certify
that  the  information  set  forth  in  this  Schedule  TO is true, complete and
correct.


                                 EVOLVE  SOFTWARE,  INC.


                                 By: /s/  Kenneth  J.  Bozzini
                                     -------------------------------------------
                                     Kenneth  J.  Bozzini
                                     Chief Financial Officer and Vice President,
                                     Finance

Date:  December 5, 2001






                                                 INDEX TO EXHIBITS


  EXHIBIT
  NUMBER     DESCRIPTION
-----------  ---------------------------------------------------------------------------------------------------
          

  (a)(1)(i)  Offer to Exchange Certain Outstanding Options for New Options, dated December 5, 2001.
 (a)(1)(ii)  Election Form.
(a)(1)(iii)  Letter from Chairman to Employees, dated December 5, 2001.
 (a)(1)(iv)  Form of Notice to Withdraw from the Offer.
  (a)(1)(v)  Form of Promise to Grant Stock Option(s).
  (a)(5)(i)  Evolve Software, Inc. Amended and Restated 2000 Stock Plan.
 (a)(5)(ii)  Form of agreement under Evolve Software, Inc. Amended and Restated 2000 Stock Plan.
(a)(5)(iii)  Evolve Software, Inc. 2000 Stock Plan Prospectus.
   (d)(1)    Certificate of Designation of Evolve Software, Inc. Series A Preferred Stock, filed as Exhibit 10.4
             to the Company's Current Report on Form 8-K/A filed on October 3, 2001, and incorporated herein by
             reference.
   (d)(2)    Form of Form A Subscription Warrant and Form of Form B Subscription Warrant, filed as Exhibit 10.2
             to the Company's Current Report on Form 8-K/A filed on October 3, 2001, and incorporated herein by
             reference.
   (d)(3)    Form of Warrant to Purchase Shares of Common Stock, filed as Exhibit 10.3 to the Company's Current
             Report on Form 8-K/A filed on October 3, 2001, and incorporated herein by reference.